The number of people with susceptibility test result for rifampicin in Paraguay

Paraguay: The number of people with susceptibility test result for rifampicin was 1,639 in 2021. ▲ Rising

Latest (2021)
1,639
Change on year
up 113.4%
World rank
56th
of 155 countries
All-time high
1,639
in 2021
All-time low
428
in 2018
Years of data
5
2017–2021

The number of people with susceptibility test result for rifampicin in Paraguay, 2017–2021

5007501.0k1.2k1.5k1.8k2017201920212017: 8712018: 4282019: 8192020: 7682021: 1.6k

Source: World Health Organization, Global Health Observatory.

Analysis

The most recent figure for the number of people with susceptibility test result for rifampicin in Paraguay is 1,639, measured in 2021. That is the highest value across all 5 years on record.

The figure is up 113.4% on the previous year and up 88.2% over five years.

That places Paraguay 56th out of 155 countries with data for 2021, putting it in the middle of the range.

The number of people with susceptibility test result for rifampicin in Paraguay, year by year

Annual values for The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients. in Paraguay, 2017 to 2021.
Year Value Change
2017 871
2018 428 -50.9%
2019 819 +91.4%
2020 768 -6.2%
2021 1,639 +113.4%

Paraguay compared with similar countries

  • Paraguay's 1,639 is above the median for upper middle income countries, which is 880, 1.9× the median. (46 countries reporting)
  • Paraguay's 1,639 is above the median for Latin America & Caribbean, which is 406.5, 4.0× the median. (26 countries reporting)

Averages by decade

DecadeAverage LowestHighest Years
2010s 706 428 871 3
2020s 1,204 768 1,639 2

Countries ranked near Paraguay

  1. 53 Chile 1,772 compare
  2. 54 United Kingdom of Great Britain and Northern Ireland 1,734 compare
  3. 55 Dominican Republic 1,724 compare
  4. 57 Liberia 1,486 compare
  5. 58 Germany 1,440 compare
  6. 59 Azerbaijan 1,409 compare

See the full ranking of 157 places →

More health data for Paraguay

All data for Paraguay →

Frequently asked questions

What is the number of people with susceptibility test result for rifampicin in Paraguay?
The number of people with susceptibility test result for rifampicin in Paraguay was 1,639 in 2021, according to World Health Organization, Global Health Observatory.
What is the highest the number of people with susceptibility test result for rifampicin recorded in Paraguay?
The highest recorded value was 1,639 in 2021.
What is the lowest the number of people with susceptibility test result for rifampicin recorded in Paraguay?
The lowest recorded value was 428 in 2018.
How does Paraguay rank for the number of people with susceptibility test result for rifampicin?
Paraguay ranks 56th out of 155 countries with data for 2021.
Where does this Paraguay data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

The number of people with susceptibility test result for rifampicin in Paraguay. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 15 September 2026, from https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/paraguay/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/the-number-of-people-with-susceptibility-test-result-for-rifampicin-among/paraguay/">The number of people with susceptibility test result for rifampicin in Paraguay</a> — Statizoid

About this data

Indicator
The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
157 places, 785 data points, 2017–2021
Last refreshed